Alex Kelly

Interim Chief Financial Officer

Alex is Interim Chief Financial Officer at Precision BioSciences. He was previously Chief Corporate Affairs Officer when he joined Precision in October 2020. Alex joined Precision from Allergan, where he served as Executive Vice President, Corporate Affairs and Chief Communications Officer and President of The Allergan Foundation. In these roles, Alex developed internal and external messaging that shaped the company culture and supported several successful company transformations including the recent merger with AbbVie. Previously, Alex served as Senior Vice President, Chief Integration Officer for Actavis where he led back-to-back integration efforts for both the acquisition of Forest Labs and Allergan. Prior to this role, he was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations at Forest Labs where he built a consolidated corporate communications and investor relations team and led integration efforts. Alex has held additional roles at Bausch + Lomb, Merck, Schering-Plough, Novartis, Pharmacia, and Pharmacia & Upjohn. Currently, Alex is the Vice Chair of the California Life Sciences Association. He earned his Bachelor of Science in Pharmacy from Purdue University. When he is not working, Alex likes to spend time with his wife (preferably by a beach), attend his kid’s activities, garden, cook and run 100 miles every month.